CVS Health (CVS) PT Raised to $107 at RBC Capital

May 7, 2026 8:23 AM

RBC Capital analyst Ben Hendrix raised the price target on CVS Health (NYSE: CVS) to $107.00 (from $93.00) while maintaining a Outperform rating.

No results found